Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Inventory (2020 - 2025)

Cellebrite DI has reported Inventory over the past 6 years, most recently at $7.6 million for Q4 2025.

  • Quarterly results put Inventory at $7.6 million for Q4 2025, down 14.95% from a year ago — trailing twelve months through Dec 2025 was $7.6 million (down 14.95% YoY), and the annual figure for FY2025 was $7.6 million, down 14.95%.
  • Inventory for Q4 2025 was $7.6 million at Cellebrite DI, down from $8.9 million in the prior quarter.
  • Over the last five years, Inventory for CLBT hit a ceiling of $10.2 million in Q4 2022 and a floor of $6.5 million in Q4 2021.
  • Median Inventory over the past 5 years was $8.9 million (2024), compared with a mean of $8.6 million.
  • Biggest five-year swings in Inventory: soared 56.29% in 2022 and later dropped 14.95% in 2025.
  • Cellebrite DI's Inventory stood at $6.5 million in 2021, then soared by 56.29% to $10.2 million in 2022, then decreased by 2.32% to $9.9 million in 2023, then decreased by 10.07% to $8.9 million in 2024, then dropped by 14.95% to $7.6 million in 2025.
  • The last three reported values for Inventory were $7.6 million (Q4 2025), $8.9 million (Q4 2024), and $9.9 million (Q4 2023) per Business Quant data.